0300854474058

SCHERING-PLOUGH/SCHERING LABS AFRIN SEVERE

300854474058

About this product

Written automatically from public information, so it may contain mistakes.

I've searched for information on the barcode 300854474058 reported as SCHERING-PLOUGH/SCHERING LABS AFRIN SEVERE. Here's what I found:

SCHERING-PLOUGH/SCHERING LABS AFRIN SEVERE is a prescription medication used to treat acute angle-closure glaucoma and ocular hypertension (high pressure in the eye). It contains the active ingredient Acetazolamide, which is an oral carbonic anhydrase inhibitor.

The medication works by decreasing the fluid produced in the eye, thereby reducing intraocular pressure. However, it can cause various side effects, including:

  • Diarrhea
  • Nausea and vomiting
  • Dizziness
  • Headache
  • Fatigue

There are also some warnings and concerns associated with this product:

  • Allergic reactions, such as hives or itching, may occur in rare cases.
  • The medication can cause a decrease in blood pressure, which may lead to dizziness or fainting.
  • Acetazolamide can interact with other medications, including blood thinners, and reduce their effectiveness.

As for prices, they vary depending on the location, pharmacy, and quantity. On average, a 0.5g packet of Afrin Severe tablets may cost around $15-$30 USD, while a 1g packet may range from $20-$40 USD.

Please note that this information is based on publicly available data and may not reflect the most up-to-date pricing or availability. Additionally, it's essential to consult with a healthcare professional before taking any medication, as they can provide personalized advice and guidance.

Health-related disclaimer: As Afrin Severe is a prescription medication, there is no specific health-related disclaimer for consumable products. However, users should always follow the recommended dosage and instructions provided by their healthcare provider, and be aware of potential interactions with other medications or conditions.

How often it is looked up

Today
3
Last 7 days
6
Last 30 days
15
All time
174

Comments 0

No comments yet. Be the first to share your thoughts!